Provided by Tiger Trade Technology Pte. Ltd.

Editas Medicine

3.28
+0.28009.33%
Pre-market: 3.310.0300+0.91%06:14 EDT
Volume:4.21M
Turnover:13.60M
Market Cap:501.84M
PE:-4.49
High:3.33
Open:3.05
Low:3.05
Close:3.00
52wk High:4.54
52wk Low:1.66
Shares:153.00M
Float Shares:115.00M
Volume Ratio:1.04
T/O Rate:3.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7307
EPS(LYR):-1.8036
ROE:-118.82%
ROA:-23.29%
PB:4.77
PE(LYR):-1.82

Loading ...

Mar 05, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 05, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Major Issues Report

Form 8-K - Current report
Dec 12, 2024

Major Issues Report

Form 8-K - Current report
Dec 10, 2024

Major Issues Report

Form 8-K - Current report
Nov 04, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Oct 22, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities